These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 10897009

  • 1. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer.
    Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, Oberley LW, Yan T, Zhong W, Jiang X, Oberley TD.
    Cancer; 2000 Jul 01; 89(1):123-34. PubMed ID: 10897009
    [Abstract] [Full Text] [Related]

  • 2. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG, Qian J, Maihle NJ.
    Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 01; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 4. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
    Hull D, Ma J, Singh H, Hossain D, Qian J, Bostwick DG.
    BJU Int; 2009 Oct 01; 104(7):915-8. PubMed ID: 19388995
    [Abstract] [Full Text] [Related]

  • 5. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.
    Clin Cancer Res; 1999 Dec 01; 5(12):4105-10. PubMed ID: 10632347
    [Abstract] [Full Text] [Related]

  • 6. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients.
    Cheng YK, Hwang GY, Lin CD, Tsai MH, Tsai SW, Chang WC.
    Laryngoscope; 2006 Mar 01; 116(3):417-22. PubMed ID: 16540901
    [Abstract] [Full Text] [Related]

  • 7. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145.
    Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK.
    Carcinogenesis; 2004 Aug 01; 25(8):1359-70. PubMed ID: 15044326
    [Abstract] [Full Text] [Related]

  • 8. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats.
    Chan SH, Tai MH, Li CY, Chan JY.
    Free Radic Biol Med; 2006 Jun 01; 40(11):2028-39. PubMed ID: 16716903
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of manganese superoxide dismutase and catalase in lung cancer.
    Chung-man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC.
    Cancer Res; 2001 Dec 01; 61(23):8578-85. PubMed ID: 11731445
    [Abstract] [Full Text] [Related]

  • 10. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue.
    Cookson MS, Reuter VE, Linkov I, Fair WR.
    J Urol; 1997 Feb 01; 157(2):673-6. PubMed ID: 8996396
    [Abstract] [Full Text] [Related]

  • 11. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
    Zhang W, Kapusta LR, Slingerland JM, Klotz LH.
    Cancer Res; 1998 Feb 15; 58(4):619-21. PubMed ID: 9485010
    [Abstract] [Full Text] [Related]

  • 12. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V, Dargère D, Laurendeau I, Benoît G, Vidaud M, Jardin A, Bedossa P.
    J Pathol; 1999 Oct 15; 189(2):213-8. PubMed ID: 10547577
    [Abstract] [Full Text] [Related]

  • 13. Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
    Bostwick DG, Meiers I, Shanks JH.
    Hum Pathol; 2007 Sep 15; 38(9):1394-401. PubMed ID: 17555796
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
    Montironi R, Lucarini G, Castaldini C, Galluzzi CM, Biagini G, Fabris G.
    Anticancer Res; 1996 Sep 15; 16(4A):2057-62. PubMed ID: 8712742
    [Abstract] [Full Text] [Related]

  • 15. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 Sep 15; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 16. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul 15; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW.
    BJU Int; 2007 Apr 15; 99(4):908-15. PubMed ID: 17378849
    [Abstract] [Full Text] [Related]

  • 18. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR.
    Clin Cancer Res; 2002 Sep 15; 8(9):2912-23. PubMed ID: 12231536
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S, Sen R, Kalra R, Arora B, Sharma P, Gahlawat S.
    Indian J Pathol Microbiol; 2006 Oct 15; 49(4):495-9. PubMed ID: 17183836
    [Abstract] [Full Text] [Related]

  • 20. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
    Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, Ozgök Y, Dimovski A.
    Clin Biochem; 2006 Feb 15; 39(2):176-9. PubMed ID: 16413012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.